BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15546800)

  • 1. Dysfunctional B cells in systemic lupus erythematosus.
    Renaudineau Y; Pers JO; Bendaoud B; Jamin C; Youinou P
    Autoimmun Rev; 2004 Nov; 3(7-8):516-23. PubMed ID: 15546800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes on the front line of autoimmunity.
    Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
    Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in the understanding of B-cell functions in autoimmunity.
    Porakishvili N; Mageed R; Jamin C; Pers JO; Kulikova N; Renaudineau Y; Lydyard PM; Youinou P
    Scand J Immunol; 2001; 54(1-2):30-8. PubMed ID: 11439145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.
    Youinou P; Renaudineau Y
    Thromb Res; 2004; 114(5-6):363-9. PubMed ID: 15507266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell conducts the lymphocyte orchestra.
    Youinou P
    J Autoimmun; 2007; 28(2-3):143-51. PubMed ID: 17363215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell biology and dysfunction in SLE.
    Anolik JH
    Bull NYU Hosp Jt Dis; 2007; 65(3):182-6. PubMed ID: 17922667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity.
    Hughes GC; Clark EA
    Autoimmunity; 2007 Sep; 40(6):470-81. PubMed ID: 17729041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 and the Th17 lineage in systemic lupus erythematosus.
    Garrett-Sinha LA; John S; Gaffen SL
    Curr Opin Rheumatol; 2008 Sep; 20(5):519-25. PubMed ID: 18698171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5: a safeguard against autoimmunity and a shield for cancer cells.
    Dalloul A
    Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of immunity and tolerance in renal diseases].
    Ranieri E
    G Ital Nefrol; 2005; 22(2):140-51. PubMed ID: 15875277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.